Skip to content

A Comparison of 5 Low Volume Bowel Preparations

A Randomized Comparison of Five Low Volume Bowel Preparations for Colonoscopy

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01719653
Enrollment
1079
Registered
2012-11-01
Start date
2012-10-31
Completion date
2014-09-30
Last updated
2017-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bowel Preparation for Colonoscopy

Keywords

Colonoscopy, Bowel Preparation, MiraLAX, Gatorade, PEG-3350, MoviPrep, SUPREP, Chicago Bowel Preparation Scale, Boston Bowel Preparation Scale

Brief summary

The purpose of this investigation is to compare 3 versions of MiraLAX/Gatorade, MoviPrep and SUPREP to see which preparation cleanses the colon best and which preparation is best tolerated.

Interventions

MiraLAX consumed as described in each arm.

Gatorade consumed as described in each arm.

MoviPrep consumed as described in each arm.

DRUGSUPREP

SUPREP consumed as described in each arm.

Sponsors

Gastroenterology Services, Ltd.
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Patients at least 18 years old planning to undergo an elective colonoscopy will be eligible for inclusion in our study. We would prefer to exclude as few groups as possible since in clinical practice these less well studied groups often need a colonoscopy and will need to have a colonoscopy preparation.

Exclusion criteria

1. Patients who are allergic (this is very rare) or intolerant to any of the study drugs. 2. Patients who are pregnant. 3. Patients who required multiple day colon preparations (2 days prior and 1 day prior) in the past will be excluded. 4. Patients with ileus, gastrointestinal obstruction, gastric retention, bowel perforation, toxic colitis or toxic megacolon would not be considered elective colonoscopies and are excluded. 5. Patients with known renal disease (baseline creatinine greater than 1.50 mg/dl) will need to be excluded due to the magnesium in SUPREP which is contraindicated in patients with significant renal disease.

Design outcomes

Primary

MeasureTime frameDescription
Chicago Bowel Preparation ScaleAt completion of colonoscopy - day 1The quality of the colon preparation as graded using our new Chicago Bowel Preparation Scale (BPS) (Adventist Midwest Region Institutional Review Board, AMH 2010-01-80; ClinicalTrials.gov NCT01063049). Chicago BPS total score is ranges from 0 (very poor) to 36 (outstanding). Modified Chicago BPS total score is ranges from 0 (very poor) to 33 (outstanding). Chicago BPS Fluid score is ranges from 0 (dry) to 3 (wet).

Secondary

MeasureTime frameDescription
Boston Bowel Preparation ScaleAt completion of colonoscopy - day 1The quality of the colon preparation as graded using Boston Bowel Preparation total scores is range from 0 (very poor) to 9 (outstanding).
Adequate/Inadequate ScaleAt completion of colonoscopy - day 1The cleanliness of the colon as rated by the gastroenterologist using an adequate/inadequate scale where an adequate preparation is defined as being able to see at least 95% of the mucosa of the colon after washing and suctioning; otherwise, the preparation is rated as inadequate.

Countries

United States

Participant flow

Participants by arm

ArmCount
MiraLAX 306 g (Day-Prior)
MiraLAX 306 g and Gatorade 64 oz (1/2 gallon) consumed the day-prior to the colonoscopy as follows: Miralax 51 g at 12 noon; Gatorade 64 oz mixed with Miralax 255 g from about 6 PM to 9 PM MiraLAX: MiraLAX consumed as described in each arm. Gatorade: Gatorade consumed as described in each arm.
200
MiraLAX 357 g (Day-Prior)
MiraLAX 357 g and Gatorade 64 oz (1/2 gallon) consumed the day-prior to the colonoscopy as follows: Miralax 68 g at 12 noon; Gatorade 64 oz mixed with Miralax 289 g from about 6 PM to 9 PM. MiraLAX: MiraLAX consumed as described in each arm. Gatorade: Gatorade consumed as described in each arm.
200
MiraLAX 306 g (Split-Dose)
MiraLAX 306 g and Gatorade 64 oz (1/2 gallon) consumed as a split-dose as follows: Gatorade 32oz mixed with Miralax 153 g from about 6 PM to 8 PM the day prior to the colonoscopy; Gatorade 32oz mixed with Miralax 153 g from about 2-4 hours prior to the colonoscopy. MiraLAX: MiraLAX consumed as described in each arm. Gatorade: Gatorade consumed as described in each arm.
200
MoviPrep (Split-Dose)
MoviPrep consumed as a split-dose as follows: MoviPrep 1 liter consumed from about 6 PM to 7 PM the day prior to the colonoscopy followed by 0.5 liter of clear liquids; MoviPrep 1 liter consumed from 3-4 hours prior to the colonoscopy followed by 0.5 liter of clear liquids. MoviPrep: MoviPrep consumed as described in each arm.
200
SUPREP (Split-Dose)
SUPREP consumed as a split-dose as follows: SUPREP 16 oz consumed from about 6 PM to 7 PM the day prior to the colonoscopy followed by 32 oz of clear liquids; SUPREP 16 oz consumed from 3-4 hours prior to the colonoscopy followed by 32 oz of clear liquids. SUPREP: SUPREP consumed as described in each arm.
200
Total1,000

Baseline characteristics

CharacteristicMiraLAX 306 g (Day-Prior)MiraLAX 357 g (Day-Prior)MiraLAX 306 g (Split-Dose)MoviPrep (Split-Dose)SUPREP (Split-Dose)Total
Age, Continuous60.9 years
STANDARD_DEVIATION 12.7
61.3 years
STANDARD_DEVIATION 12.4
59.1 years
STANDARD_DEVIATION 11.3
60.1 years
STANDARD_DEVIATION 11.4
60.6 years
STANDARD_DEVIATION 11.2
60.4 years
STANDARD_DEVIATION 11.8
Region of Enrollment
United States
200 participants200 participants200 participants200 participants200 participants1000 participants
Sex: Female, Male
Female
99 Participants99 Participants101 Participants97 Participants99 Participants495 Participants
Sex: Female, Male
Male
101 Participants101 Participants99 Participants103 Participants101 Participants505 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
EG004
affected / at risk
deaths
Total, all-cause mortality
0 / 2000 / 2000 / 2000 / 2000 / 200
other
Total, other adverse events
119 / 200122 / 200126 / 200110 / 200111 / 200
serious
Total, serious adverse events
0 / 2000 / 2000 / 2000 / 2000 / 200

Outcome results

Primary

Chicago Bowel Preparation Scale

The quality of the colon preparation as graded using our new Chicago Bowel Preparation Scale (BPS) (Adventist Midwest Region Institutional Review Board, AMH 2010-01-80; ClinicalTrials.gov NCT01063049). Chicago BPS total score is ranges from 0 (very poor) to 36 (outstanding). Modified Chicago BPS total score is ranges from 0 (very poor) to 33 (outstanding). Chicago BPS Fluid score is ranges from 0 (dry) to 3 (wet).

Time frame: At completion of colonoscopy - day 1

ArmMeasureGroupValue (MEAN)Dispersion
MiraLAX 306 g (Day-Prior)Chicago Bowel Preparation ScaleChicago BPS Total Score33.54 units on a scaleStandard Deviation 4.28
MiraLAX 306 g (Day-Prior)Chicago Bowel Preparation ScaleChicago BPS Fluid Score0.90 units on a scaleStandard Deviation 0.83
MiraLAX 306 g (Day-Prior)Chicago Bowel Preparation ScaleModified Chicago BPS Total Score31.82 units on a scaleStandard Deviation 3.59
MiraLAX 357 g (Day-Prior)Chicago Bowel Preparation ScaleModified Chicago BPS Total Score32.14 units on a scaleStandard Deviation 3.69
MiraLAX 357 g (Day-Prior)Chicago Bowel Preparation ScaleChicago BPS Total Score34.00 units on a scaleStandard Deviation 4.25
MiraLAX 357 g (Day-Prior)Chicago Bowel Preparation ScaleChicago BPS Fluid Score1.03 units on a scaleStandard Deviation 0.89
MiraLAX 306 g (Split-Dose)Chicago Bowel Preparation ScaleModified Chicago BPS Total Score32.33 units on a scaleStandard Deviation 2.93
MiraLAX 306 g (Split-Dose)Chicago Bowel Preparation ScaleChicago BPS Total Score34.67 units on a scaleStandard Deviation 3.58
MiraLAX 306 g (Split-Dose)Chicago Bowel Preparation ScaleChicago BPS Fluid Score1.84 units on a scaleStandard Deviation 0.9
MoviPrep (Split-Dose)Chicago Bowel Preparation ScaleChicago BPS Total Score34.95 units on a scaleStandard Deviation 3.39
MoviPrep (Split-Dose)Chicago Bowel Preparation ScaleChicago BPS Fluid Score1.45 units on a scaleStandard Deviation 0.82
MoviPrep (Split-Dose)Chicago Bowel Preparation ScaleModified Chicago BPS Total Score32.54 units on a scaleStandard Deviation 2.92
SUPREP (Split-Dose)Chicago Bowel Preparation ScaleModified Chicago BPS Total Score32.65 units on a scaleStandard Deviation 1.72
SUPREP (Split-Dose)Chicago Bowel Preparation ScaleChicago BPS Total Score35.16 units on a scaleStandard Deviation 2.34
SUPREP (Split-Dose)Chicago Bowel Preparation ScaleChicago BPS Fluid Score1.30 units on a scaleStandard Deviation 0.91
Comparison: All 5 arms were compared pair-wise.~1=G+PEG-306 2=G+PEG-357 3=G+PEG-Split 4=PEG+Asc-Split 5=SS-Splitp-value: <0.005t-test, 2 sided
Secondary

Adequate/Inadequate Scale

The cleanliness of the colon as rated by the gastroenterologist using an adequate/inadequate scale where an adequate preparation is defined as being able to see at least 95% of the mucosa of the colon after washing and suctioning; otherwise, the preparation is rated as inadequate.

Time frame: At completion of colonoscopy - day 1

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
MiraLAX 306 g (Day-Prior)Adequate/Inadequate ScaleAdequate195 Participants
MiraLAX 306 g (Day-Prior)Adequate/Inadequate ScaleInadequate5 Participants
MiraLAX 357 g (Day-Prior)Adequate/Inadequate ScaleInadequate4 Participants
MiraLAX 357 g (Day-Prior)Adequate/Inadequate ScaleAdequate196 Participants
MiraLAX 306 g (Split-Dose)Adequate/Inadequate ScaleInadequate2 Participants
MiraLAX 306 g (Split-Dose)Adequate/Inadequate ScaleAdequate198 Participants
MoviPrep (Split-Dose)Adequate/Inadequate ScaleAdequate197 Participants
MoviPrep (Split-Dose)Adequate/Inadequate ScaleInadequate3 Participants
SUPREP (Split-Dose)Adequate/Inadequate ScaleInadequate3 Participants
SUPREP (Split-Dose)Adequate/Inadequate ScaleAdequate197 Participants
Comparison: All 5 arms were compared pair-wise.p-value: >0.005Chi-squared
Secondary

Boston Bowel Preparation Scale

The quality of the colon preparation as graded using Boston Bowel Preparation total scores is range from 0 (very poor) to 9 (outstanding).

Time frame: At completion of colonoscopy - day 1

ArmMeasureValue (MEAN)Dispersion
MiraLAX 306 g (Day-Prior)Boston Bowel Preparation Scale8.39 units on a scaleStandard Deviation 1.36
MiraLAX 357 g (Day-Prior)Boston Bowel Preparation Scale8.57 units on a scaleStandard Deviation 1.16
MiraLAX 306 g (Split-Dose)Boston Bowel Preparation Scale8.66 units on a scaleStandard Deviation 1.16
MoviPrep (Split-Dose)Boston Bowel Preparation Scale8.80 units on a scaleStandard Deviation 1.04
SUPREP (Split-Dose)Boston Bowel Preparation Scale8.80 units on a scaleStandard Deviation 0.77
Comparison: All 5 arms were compared pair-wise.~1=G+PEG-306 2=G+PEG-357 3=G+PEG-Split 4=PEG+Asc-Split 5=SS-Splitp-value: <0.001t-test, 2 sided

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026